Name the intervention
Identify the exact molecule or analogue, its target context and the formulation studied. Broad phrases such as growth hormone peptide or secretagogue can conceal important differences.
Keep a biochemical measurement separate from a clinical outcome. A change in a hormone-related marker does not independently establish improved function, appearance or long-term health.
A specific tesamorelin example
The tesamorelin profile links a randomized trial in adults with HIV-associated abdominal fat accumulation and a named approved-product label. That is a specific clinical context, not general proof of weight-loss benefit in all populations.
Do not transfer those findings to an unrelated secretagogue or an unspecified blend. The relevant product, indication, route and comparison need to remain attached to the result.
Combination claims need combination evidence
A proposed combination may have a plausible rationale without a controlled study showing an advantage. To assess it, identify whether the cited work tested the exact combination or only the ingredients separately.
A claim of synergy needs an appropriate experimental comparison. Seeing effects in two separate papers does not demonstrate that combining the compounds produces a larger benefit or an acceptable risk profile.
A reading framework
Use the evidence index to find original sources, then record their scope in a compact comparison. This page is an interpretation framework, not a ranking of compounds or a treatment plan.
| Dimension | Keep explicit |
|---|---|
| Intervention | Exact molecule, analogue or combination |
| Setting | Population, condition and study design |
| Measurement | Marker or actual clinical endpoint |
| Comparison | Comparator and follow-up period |
| Safety context | What was assessed and what remains uncertain |